Weekly semaglutide bests placebo for greater weight loss
New research on Alzheimer’s disease shows ‘lifestyle origin at least in some degree’
1 April 2021Europe badly lags US in jabs-in-arms race
1 April 2021Weekly semaglutide bests placebo for greater weight loss
(HealthDay)—Once-weekly subcutaneous semaglutide results in significantly greater weight loss than placebo when used as adjunctive therapy over 68 weeks in adults with overweight or obesity, according to a study published online Feb. 24 in the Journal of the American Medical Association.
